XGEN Pharmaceuticals is a Business Corporation registed in Alaska. Founded in June 2020, with the entity number 10134957. The entity did not apply for any business licenses yet. Currently in Revoked. XGEN Pharmaceuticals has 4 key officers and 3 shareholders.
| Legal Name: | X-GEN Pharmaceuticals, Inc. |
| Entity Type: |
Business Corporation
X-GEN Pharmaceuticals, Inc. is structured as a Business Corporation, a common type of corporate entity designed to conduct a wide range of business activities. In Alaska, a Business Corporation (often referred to as a "C-Corp") is a separate legal entity from its owners (shareholders), offering them limited liability protection and enabling the company to raise capital through the issuance of stock. |
| Status: |
Revoked
"Revoked" status means that the State of Alaska has officially terminated the registration of X-GEN Pharmaceuticals, Inc. due to non-compliance with state regulations. This typically involves a failure to maintain a registered agent, file annual reports, or pay required fees. A company with a "Revoked" status is no longer permitted to operate legally within the state. |
| AK Formed Date: | 11 Jun 2020 (5 years ago) |
| Duration: | Perpetual |
| Branch of: | X-GEN Pharmaceuticals, Inc., NEW YORK (Company Number 2880782) |
| Entity Number: |
10134957
The entity number, 10134957, is a unique identifier assigned by the Alaska Department of Commerce, Community, and Economic Development to X-GEN Pharmaceuticals, Inc.. This number can be used to verify the company's registration and access official records. |
| Home State: | NEW YORK |
| Entity Mailing Address: | 300 DANIEL ZENKER DRIVE, HORSEHEADS, NY 14845 |
| Name | Role | Shares |
|---|---|---|
| INCORP SERVICES, INC. | Registered Agent | - |
| Catherine Liles | Shareholder, Treasurer | 15.00 |
| Jay Liles | Shareholder, Vice President | 25.00 |
| Susan Badia | President, Shareholder | 60.00 |
Date of last update: 15 Feb 2025
Sources: State of Alaska - Department of Commerce, Community, and Economic Development
